
Governmental Policy Levers: Navigating Drug Pricing Across Agencies and Congress
Coming soon to iPhone. Already have it? “Listen in Starcast” takes you straight there.
On this episode
About this episode
In this first part of our series in collaboration with White & Case and BRG , Wayne chat s with Bethany Hills, P artner at White & Case's New York office ; Rahul Rao , Partner in White & Case's Washington, D.C., office ; and John Barkett, Managing Director in BRG's Healthcare Transactions and Strategy practice. Together, they discuss FDA and product-strategy decisions that actually determine future pricing power developments ; how certain factors shape market structure in ways that could attract anti-trust scrutiny; the line between lawful regulatory strategy and conduct that regulators or plaintiffs may characterize as competition-distorting ; how management teams should think about…